Welcome to our dedicated page for Tabula Rasa Heal news (Ticker: TRHC), a resource for investors and traders seeking the latest updates and insights on Tabula Rasa Heal stock.
Tabula Rasa HealthCare, Inc. (NASDAQ: TRHC) provides investors and healthcare professionals with essential updates through this centralized news resource. As a leader in value-based care solutions, TRHC specializes in medication risk management and technology-driven healthcare optimization for at-risk populations.
This page aggregates official announcements including strategic partnerships, financial disclosures, and operational developments. Users will find updates on TRHC's pending merger with ExactCare Pharmacy under Nautic Partners, clinical program expansions, and innovations in personalized medication management systems.
Key content categories include earnings reports, merger/acquisition details, regulatory filings, and partnership announcements with PACE programs. All information is sourced directly from company communications to ensure accuracy and timeliness.
Bookmark this page for streamlined access to TRHC's latest developments in healthcare technology and pharmacy services. For historical data and investor materials, visit the company's Investor Relations portal through their official website.
Rittenhouse Ventures, a venture capital firm specializing in early-stage software investments, has announced the successful closing of Fund III. The firm now manages over $75M in assets and focuses on capital-efficient B2B software, AI, and tech-enabled services companies.
The fund has already made initial investments in four portfolio companies: GoMo Health, Pieces Technologies, WealthHub Solutions, and High QA. Notable past investments include Tabula Rasa HealthCare (NASDAQ: TRHC) and AppsFlyer. The firm has strengthened its leadership with two new partners: David Nevas, former Partner at Edison Partners, and Sushma Rajagopalan, former CEO of ITC Infotech.
Rittenhouse targets companies with $2M-$10M in revenue, typically investing in rounds of $5M or less, with a particular focus on the Mid-Atlantic region and underserved markets.
Tabula Rasa HealthCare (TRHC) has scheduled a conference call and webcast for May 9, 2023, at 8:30 a.m. EDT to discuss its first quarter 2023 financial results. The financial results will be released after market close on May 8, 2023. TRHC focuses on medication safety solutions, utilizing proprietary technology like MedWise® to optimize medication regimens, minimize adverse drug events, and reduce healthcare costs. Their clinical tele-pharmacy network enhances patient care nationwide, and their services are trusted by health plans and at-risk provider groups for value-based care initiatives.
Tabula Rasa HealthCare (TRHC) has appointed Brian Adams as President and Chief Executive Officer, effective immediately. Adams, who was previously interim CEO, will also join the Board of Directors. Richard W. Rew II has been named Chief Legal Officer and Corporate Secretary, effective April 10, 2023. The company announced preliminary unaudited revenue for Q1 2023, expected to be between $87.0 million and $88.5 million, exceeding prior guidance of $82 million to $84 million. The company plans to report full financial results in early May. The new leadership aims to advance solutions for the Program of All-Inclusive Care for the Elderly (PACE) market and improve patient care.
Tabula Rasa HealthCare (TRHC) reported a strong fourth quarter for 2022, achieving $82.7 million in revenue, a 20% increase year-over-year. Despite this growth, the company recorded a GAAP net loss of $18.4 million, up from $13.0 million the previous year. Full-year revenue reached $299.5 million, a 15% increase, but the net loss grew to $77.3 million. The company has made strategic moves, including leadership changes and the divestiture of non-core businesses, to focus on sustainable growth. Looking ahead, TRHC projects revenue for 2023 to be between $343 million and $354 million, with adjusted EBITDA guidance of $17 million to $20 million.
FAQ
What is the market cap of Tabula Rasa Heal (TRHC)?
